We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
This item is currently unavailable
The 2023-2028 World Outlook for Anti-HA Antibodies
Price data last checked 147 day(s) ago - refreshing...
One email. No newsletter. No nudges.
Gone for 176 days. Could come back at any time — we're watching for you.
Out of stock 176 days · last price £795 · longest previous gap was 1 days
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 584 days • 584 data points (No recent data available)
Price Distribution
Price distribution over 584 days • 1 price levels
Price Analysis
Most common price: £795 (584 days, 100.0%)
Price range: £795 - £795
Price levels: 1 different prices over 584 days
Product Specifications
- Format
- paperback
- ASIN
- B09WCHCPPP
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 10 May 2022
- Listed Since
- 25 April 2022
Similar Products You Might Like
The 2025-2030 World Outlook for Custom Antibodies
The 2023-2028 World Outlook for AntiCD20 Monoclonal Antibodies
The 2023-2028 World Outlook for Custom Antibodies
The 2025-2030 World Outlook for Antibody Drug Conjugates
The 2025-2030 World Outlook for Phage Display Antibody Library Technologies
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
Therapeutic Antibodies: Methods and Protocols: 525 (Methods in Molecular Biology, 525)
Humana
The 2023-2028 World Outlook for Neuroscience Antibodies and Assays
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States
The 2023-2028 World Outlook for Heparin Anticoagulants
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India
The 2025-2030 World Outlook for Heparin Anticoagulants
The 2023-2028 Outlook for Monoclonal Antibodies Protein Therapeutics in Japan
The 2026-2031 World Outlook for Unfractionated Heparin
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in North America & the Caribbean
The 2023-2028 World Outlook for Human Serum Albumin
The 2023-2028 Outlook for Anticoagulants in the United States
The 2023-2028 Outlook for Unfractionated Heparin in India
The 2023-2028 Outlook for Unfractionated Heparin in the United States
The 2025-2030 World Outlook for Immunohematology Analyzers and Reagents
The 2023-2028 Outlook for Anticoagulants in India
The 2025-2030 World Outlook for Human Serum Albumin
